Your browser doesn't support javascript.
loading
Being Kind to Your Future Self: Probability Discounting of Health Decision-Making.
Bruce, Jared M; Bruce, Amanda S; Catley, Delwyn; Lynch, Sharon; Goggin, Kathleen; Reed, Derek; Lim, Seung-Lark; Strober, Lauren; Glusman, Morgan; Ness, Abigail R; Jarmolowicz, David P.
Afiliación
  • Bruce JM; University of Missouri-Kansas City, Kansas City, MO, USA.
  • Bruce AS; Department of Pediatrics, University of Kansas Medical Center, 3901 Rainbow Blvd Mail Stop 4004, Kansas City, KS, 66160, USA. abruce@kumc.edu.
  • Catley D; Children's Mercy Hospital, Kansas City, MO, USA. abruce@kumc.edu.
  • Lynch S; University of Missouri-Kansas City, Kansas City, MO, USA.
  • Goggin K; Department of Neurology, University of Kansas Medical Center, Kansas City, KS, 66160, USA.
  • Reed D; Children's Mercy Hospital, Kansas City, MO, USA.
  • Lim SL; University of Kansas, Lawrence, KS, USA.
  • Strober L; University of Missouri-Kansas City, Kansas City, MO, USA.
  • Glusman M; Kessler Foundation, West Orange, NJ, USA.
  • Ness AR; University of Missouri-Kansas City, Kansas City, MO, USA.
  • Jarmolowicz DP; University of Missouri-Kansas City, Kansas City, MO, USA.
Ann Behav Med ; 50(2): 297-309, 2016 Apr.
Article en En | MEDLINE | ID: mdl-26669602
INTRODUCTION: Nearly 50 % of patients with chronic medical illness exhibit poor treatment adherence. When making treatment decisions, these patients must balance the probability of current side effects against the probability of long-term benefits. This study examines if the behavioral economic construct of probability discounting can be used to explain treatment decisions in chronic disease. METHODS: Thirty-eight nonadherent and 39 adherent patients with multiple sclerosis (MS) completed a series of hypothetical treatment scenarios with varied risk and benefit probabilities. RESULTS: As described by a hyperbolic probability discounting model, all patients reported decreased medication initiation as the probability of treatment efficacy decreased and the probability of treatment side effects increased. When compared to adherent patients, nonadherent patients significantly devalued treatment efficacy and inflated treatment risk. DISCUSSION: The methods in this study can be used to identify optimal risk/benefit ratios for treatment development and inform the process by which patients make treatment decisions.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Recompensa / Cooperación del Paciente / Toma de Decisiones / Descuento por Demora / Esclerosis Múltiple Tipo de estudio: Prognostic_studies / Qualitative_research Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Behav Med Asunto de la revista: CIENCIAS DO COMPORTAMENTO Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Recompensa / Cooperación del Paciente / Toma de Decisiones / Descuento por Demora / Esclerosis Múltiple Tipo de estudio: Prognostic_studies / Qualitative_research Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Behav Med Asunto de la revista: CIENCIAS DO COMPORTAMENTO Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos